Pharmaceutical Technology Editors

GS1 publishes a healthcare industry guideline describing how to implement GS1 standards to support requirements of the 2013 US Drug Supply Chain Security Act.

Texas A&M dedicates national pandemic influenza vaccine manufacturing facility.

GSK is found guilty of offering bribes to doctors and is fined $489 million.

PCI's acquisition of Biotech Services International expands the packaging services provider's presence in Europe.

Bayer separates into two entities to benefit the growth and development of Bayer Life Science and MaterialScience.

The University of Limerick will be the headquarters for a new $6.4-million research and innovation center.

EMD Serono announces a collaboration with Sutro Biopharma to develop antibody drug conjugates for multiple undisclosed targets.

GPhA throws its support behind a bill to prohibit companies from using REMS practices to deter competition.

Baxter announced that its new biopharmaceutical company will be named Baxalta when the company separates into two publicly traded companies in mid-2015.

Baxter International initiated a US voluntary recall of one lot of potassium chloride injection due to mislabeled shipping carton.

FDA approved Baxter International's treatment, RIXUBIS, for the treatment of children with hemophilia B.

The Reuters Annual Pharmaceutical Factbook reveals positive outlook for pharmaceutical industry and key insights into current trends.

Regeneron Pharmaceuticals' injection for diabetic retinopathy in patients with diabetic macular edema received FDA breakthrough therapy designation on Sept. 16, 2014.

AstraZeneca's Movantik was approved by FDA in the treatment of opioid-induced constipation.

FDA releases guidance on ANDAs and PASs submissions to help applicants avoid deficiencies.

Hospira recalled one lot of heparin due to particulate matter.

A GPhA report says generic drugs saved the US health system $239 billion in 2013.

Gerresheimer will present ready-to-fill syringes, plastic packaging products, and pharmaceutical vials at CPhI 2014.

Molecular Profiles has expanded its capsule filling capability following significant investment into new equipment at its clinical manufacturing site in the United Kingdom.

Rigaku Raman Technologies will showcase customizable handheld Raman analyzer for accurate and comprehensive raw material ID at CPhI 2014.

Bosch Packaging Technology will present four devices for processing liquid and solid pharmaceutical dosage forms at CPhI Worldwide 2014.

European Commission granted the first biosimilar insulin to receive regulatory approval in Europe.

Asterias Biotherapeutics, Cancer Research UK, and Cancer Research Technology partner for clinical trial of immunotherapy vaccine for the treatment of lung cancer.

FDA approved XTANDI for the treatment of metastatic castration-resistant prostate cancer.

PDA will publish a technical report on quality risk management aspects of drug shortages in early 2015.

Roche?s RoACTEMRA receives EU approval for use in patients with early rheumatoid arthritis.

ProBioGen, a biopharmaceutical drug manufacturer in Berlin, spends ?20 million to double its workforce.

Three-year agreement will support research on treatments for major brain disorders in Neuroscience Catalyst project.

Natoli Engineering Company partnered with the Brooklyn campus of Long Island University to open the Natoli Institute for Industrial Pharmacy Research and Development.Natoli Engineering Company announced the opening of the Natoli Institute for Industrial Pharmacy Research and Development. The institute was opened in partnership with the Arnold and Marie Schwartz College of Pharmacy and Health Sciences on the Brooklyn campus of Long Island University and features suites for dispensing, formulation, compression, and coating.

The new China facility will be Merck KGaA's biopharmaceuticals division's second largest worldwide.